The development of COVID-19 treatment

被引:118
|
作者
Yuan, Yongliang [1 ]
Jiao, Baihai [2 ]
Qu, Lili [3 ]
Yang, Duomeng [3 ]
Liu, Ruijuan [1 ]
机构
[1] Zhengzhou Univ, Dept Pharm, Affiliated Hosp 1, Zhengzhou, Henan, Peoples R China
[2] Univ Connecticut, Sch Med, Dept Med, Div Nephrol,Hlth Ctr, Farmington, CT USA
[3] Univ Connecticut, Sch Med, Dept Immunol, Hlth Ctr, Farmington, CT 06269 USA
来源
FRONTIERS IN IMMUNOLOGY | 2023年 / 14卷
基金
中国国家自然科学基金;
关键词
COVID-19; treatments; antiviral agents; neutralizing antibody therapy; Janus kinase inhibitors; JAK-STAT PATHWAY; OPEN-LABEL; CARDIOVASCULAR-DISEASE; RHEUMATOID-ARTHRITIS; RUXOLITINIB; STANDARD; MULTICENTER; FAVIPIRAVIR; TOFACITINIB; COMBINATION;
D O I
10.3389/fimmu.2023.1125246
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused a pandemic named coronavirus disease 2019 (COVID-19) that has become the greatest worldwide public health threat of this century. Recent studies have unraveled numerous mysteries of SARS-CoV-2 pathogenesis and thus largely improved the studies of COVID-19 vaccines and therapeutic strategies. However, important questions remain regarding its therapy. In this review, the recent research advances on COVID-19 mechanism are quickly summarized. We mainly discuss current therapy strategies for COVID-19, with an emphasis on antiviral agents, neutralizing antibody therapies, Janus kinase inhibitors, and steroids. When necessary, specific mechanisms and the history of therapy are present, and representative strategies are described in detail. Finally, we discuss key outstanding questions regarding future directions of the development of COVID-19 treatment.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] A Snapshot of Development and Treatment During the Time of COVID-19
    Levy-Warren, Marsha
    Tuber, Steven
    PSYCHOANALYTIC PSYCHOLOGY, 2023, 40 (03) : 147 - 148
  • [2] Recent Progress in the Development of Opaganib for the Treatment of Covid-19
    Smith, Charles
    Maines, Lynn W.
    Keller, Staci N.
    Ben-Yair, Vered Katz
    Fathi, Reza
    Plasse, Terry F.
    Levitt, Mark L.
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2022, 16 : 2199 - 2211
  • [3] Collaborative Response to COVID-19 Pandemic, and Development of Treatment Guidelines
    Peck, Kyong Ran
    INFECTION AND CHEMOTHERAPY, 2021, 53 (01): : 151 - 154
  • [4] Nanomedicine for COVID-19: the role of nanotechnology in the treatment and diagnosis of COVID-19
    Farzan Vahedifard
    Krishnan Chakravarthy
    Emergent Materials, 2021, 4 : 75 - 99
  • [5] The COVID-19 and the Paradigms of Development
    Zambrana, Juan Valdes
    Ortega, Hermes Jimenez
    Rodriguez, Mario Nodarse
    ESTUDIOS DEL DESARROLLO SOCIAL-CUBA Y AMERICA LATINA, 2023, 11 (02): : 419 - 435
  • [6] Treatment of Acute COVID-19 and COVID-19 Exposures in Children and Adolescents
    Daniels, Danielle
    Conners, Gregory P.
    PEDIATRIC EMERGENCY CARE, 2024, 40 (03) : 223 - 230
  • [7] COVID-19 Vaccine Development
    Furman, Richard R.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2022, 20 (04) : 195 - 195
  • [8] Coronavirus (COVID-19): do antibiotics aid in the treatment of COVID-19?
    Jordan, Vanessa
    JOURNAL OF PRIMARY HEALTH CARE, 2021, 13 (04) : 373 - 374
  • [9] Nanomedicine for COVID-19: the role of nanotechnology in the treatment and diagnosis of COVID-19
    Vahedifard, Farzan
    Chakravarthy, Krishnan
    EMERGENT MATERIALS, 2021, 4 (01) : 75 - 99
  • [10] Therapeutic Development in COVID-19
    Yang, Chan
    Huang, Yuan
    Liu, Shuwen
    CORONAVIRUS DISEASE - COVID-19, 2021, 1318 : 435 - 448